David R. Epstein, a director at Tempus AI , Inc. (NASDAQ:TEM), recently sold 370 shares of the company's Class A Common Stock.... Investing.com -- TD Cowen reinstated coverage on Tempus AI with a ...

Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $63.78, ...

Elizabeth Krutoholow; VP, Investor Relations; Tempus AI Inc. Jim Rogers; Chief Financial Officer; Tempus AI Inc. Eric Lefkofsky; Chief Executive Officer, Director; T ...

The latest price target for Tempus AI (NASDAQ:TEM) was reported by Needham on April 24, 2025. The analyst firm set a price target for $70.00 expecting TEM to rise to within 12 months (a possible ...

Guggenheim restated a “buy” rating on shares of Tempus AI in a research note on Tuesday, February 25th. TD Cowen reiterated a “buy” rating and issued a $74.00 target price (up previously ...

And I suspect AI and technology will produce that. We – I hope it's Tempus, but some company like Tempus will one day understand whether or not a patient is going to respond to an eGFR inhibitor ...